XML 42 R17.htm IDEA: XBRL DOCUMENT
v3.22.2

Per Share Amounts | 6 Months Ended
--- | ---
Jun. 30, 2022
Earnings per share [abstract] |
Per Share Amounts |
11. PER SHARE AMOUNTS
A) Net Earnings (Loss) Per Common Share – Basic and Diluted
| Three Months Ended |  | Six Months Ended
For the periods ended June 30, | 2022 |  | 2021 |  | 2022 |  | 2021
Net Earnings (Loss) | 2,432 |  | 224 |  | 4,057 |  | 444
Effect of Cumulative Dividends on Preferred Shares | (8) |  | (8) |  | (17) |  | (17)
Net Earnings (Loss) – Basic and Diluted | 2,424 |  | 216 |  | 4,040 |  | 427
Basic – Weighted Average Number of Shares | 1,971.3 |  | 2,017.5 |  | 1,980.6 |  | 2,017.5
Dilutive Effect of Warrants | 47.5 |  | 24.3 |  | 46.2 |  | 21.1
Dilutive Effect of Net Settlement Rights | 10.6 |  | 0.3 |  | 11.9 |  | —
Diluted – Weighted Average Number of Shares | 2,029.4 |  | 2,042.1 |  | 2,038.7 |  | 2,038.6
Net Earnings (Loss) Per Common Share – Basic ($) | 1.23 |  | 0.11 |  | 2.04 |  | 0.21
Net Earnings (Loss) Per Common Share – Diluted (1) ($) | 1.19 |  | 0.11 |  | 1.98 |  | 0.21
(1)Excluded from the calculation of the diluted net earnings (loss) per share for the three and six months ended June 30, 2022, were net earnings of $24 million and $41 million, respectively (three and six months ended June 30, 2021 – $6 million and $12 million, respectively), and common shares of 2.0 million and 1.8 million, respectively (three and six months ended June 30, 2021 – 1.9 million and 1.8 million, respectively), related to the assumed exercise of Cenovus replacement stock options as the impact was anti-dilutive. These instruments could potentially dilute earnings per share in the future. B) Common Share Dividends For the six months ended June 30, 2022, the Company paid dividends of $276 million or $0.1400 per common share (six months ended June 30, 2021 – $71 million or $0.0350 per common share). On July 27, 2022, the Company’s Board of Directors declared a third quarter base dividend of $0.1050 per common share, payable on September 29, 2022, to common shareholders of record as at September 15, 2022. The declaration of common share dividends is at the sole discretion of the Company’s Board of Directors and is considered quarterly. C) Preferred Share Dividends
| Three Months Ended |  | Six Months Ended
For the periods ended June 30, | 2022 |  | 2021 |  | 2022 |  | 2021
Series 1 First Preferred Shares | 2 |  | 2 |  | 4 |  | 4
Series 2 First Preferred Shares | — |  | — |  | — |  | —
Series 3 First Preferred Shares | 3 |  | 3 |  | 6 |  | 6
Series 5 First Preferred Shares | 2 |  | 2 |  | 4 |  | 4
Series 7 First Preferred Shares | 1 |  | 1 |  | 3 |  | 3
Total Declared and Paid Preferred Share Dividends | 8 |  | 8 |  | 17 |  | 17
The declaration of preferred share dividends is at the sole discretion of the Company’s Board of Directors and is considered quarterly. If a dividend on any preferred share is not paid in full on any dividend payment date, then a dividend restriction on the common shares shall apply. The preferred share dividends are cumulative. On July 27, 2022, the Company’s Board of Directors declared third quarter dividends for Cenovus’s preferred shares, payable on October 3, 2022, in the amount of $9 million, to preferred shareholders of record as at September 15, 2022.

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 33 -IssueDate 2021-01-01 -Section Disclosure -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfEarningsPerShareExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_EarningsPerShareAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration